EGFR and neoplasm: We conclude that the c-MET- and EGFR-targeted Db-TriTE performs equally to the parental BiTEs on single-positive target cells and shows superior binding and induction of T cell-mediated cytotoxicity on double-positive tumor cells, underlining its potential for genetic delivery by OVs and for dual-targeted T cell engagement.